Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, August 22, 2017 at 1:30 pm local time (EEST)
Biohit Oyj has received the following notification.
Person subject to the notification requirement | ||
Name: | Patrakka, Ilari | |
Position: | Other senior manager | |
Initial Notification | ||
Reference number: | 74370089ATTSNBXJVT29_20170821160015_9 | |
Issuer | ||
Name: | Biohit Oyj | |
LEI: | 74370089ATTSNBXJVT29 | |
Transaction details | ||
Transaction date: | 2017-08-17 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Exercise (Rights, Put and Call Options) | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 6482 | |
Unit price: | 3,18000 Euro | |
Aggregated transactions | ||
Volume: | 6482 | |
Volume weighted average price: | 3.18000 Euro | |
Transaction details | ||
Transaction date: | 2017-08-17 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Subscription | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 8518 | |
Unit price: | 2,27660 Euro | |
Aggregated transactions | ||
Volume: | 8518 | |
Volume weighted average price: | 2.27660 Euro | |
Transaction details | ||
Transaction date: | 2017-08-17 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 8518 | |
Unit price: | 0,00000 Euro | |
Aggregated transactions | ||
Volume: | 8518 | |
Volume weighted average price: | 0.00000 Euro | |
Transaction details | ||
Transaction date: | 2017-08-18 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Exercise (Rights, Put and Call Options) | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 5447 | |
Unit price: | 3,05000 Euro | |
Volume: | 3251 | |
Unit price: | 3,11000 Euro | |
Aggregated transactions | ||
Volume: | 8698 | |
Volume weighted average price: | 3.07243 Euro | |
Transaction details | ||
Transaction date: | 2017-08-18 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Subscription | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 2053 | |
Unit price: | 2,27660 Euro | |
Volume: | 4249 | |
Unit price: | 2,27660 Euro | |
Aggregated transactions | ||
Volume: | 6302 | |
Volume weighted average price: | 2.27660 Euro | |
Transaction details | ||
Transaction date: | 2017-08-18 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Further details: | ||
Linked to stock option programme | ||
Instrument: | Financial Instrument Linked to a Share or a Debt Instrument | |
ISIN: | FI4000219324 | |
Volume: | 2053 | |
Unit price: | 0,00000 Euro | |
Volume: | 4249 | |
Unit price: | 0,00000 Euro | |
Aggregated transactions | ||
Volume: | 6302 | |
Volume weighted average price: | 0.00000 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com